Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Total Assets (Quarterly): 115.99M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 115.99M |
| June 30, 2024 | 141.59M |
| March 31, 2024 | 167.03M |
| December 31, 2023 | 198.13M |
| September 30, 2023 | 223.02M |
| June 30, 2023 | 250.99M |
| March 31, 2023 | 277.53M |
| December 31, 2022 | 299.37M |
| September 30, 2022 | 206.37M |
| Date | Value |
|---|---|
| June 30, 2022 | 224.62M |
| March 31, 2022 | 234.27M |
| December 31, 2021 | 242.59M |
| September 30, 2021 | 258.63M |
| June 30, 2021 | 275.14M |
| March 31, 2021 | 292.94M |
| December 31, 2020 | 75.91M |
| September 30, 2020 | 88.52M |
| December 31, 2019 | 9.826M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.826M
Minimum
Dec 2019
299.37M
Maximum
Dec 2022
199.03M
Average
223.82M
Median
Total Assets (Quarterly) Benchmarks
| Organon & Co | 12.75B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 43.04M |
| Shareholders Equity (Quarterly) | 72.96M |